Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Novel Agents for Treatment of SARS-CoV-2 Infection Among High-Risk Outpatient Adults: An Adaptive Randomized Platform Trial

NCT04354428 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT04354428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04354428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Novel Agents for Treatment of SARS-CoV-2 Infection Among High-Risk Outpatient Adults: An Adaptive Randomized Platform Trial
Lead sponsor
University of Washington
Phase
Phase 2/3
Overall status
Terminated
Start date
April 16, 2020
Completion date
November 30, 2020
Enrollment
289 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2